‘Absurd, Self-Defeating’: Indian Pharma Industry Calls Out Trump’s 200% Tariff Threat

Industry experts say the actual implementation of the 200% pharmaceutical duties may take effect only by mid-to-late 2026, giving India time to negotiate or seek phased rollouts

India